Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CA.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CA.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CA.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.61ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.61ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.61EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.61EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ED.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ED.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ED.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ED.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ED.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ED.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ED.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BU.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BU.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BU.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BU.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BU.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used